Philips Secures FDA OK for Elevate Plus, Enables 30% Faster Ultrasound Imaging
PHG•Philips secured FDA 510(k) clearance for Elevate Plus on its EPIQ Elite and Affiniti ultrasound systems, introducing AI-driven Auto Measure Abdomen with over 93% accuracy and workflow automation that slashes scanning time by up to 30%. It also embeds Koios AI decision support for breast and thyroid lesion classification on-cart.
1. FDA Clearance for Elevate Plus
Philips has received FDA 510(k) clearance for Elevate Plus on its EPIQ Elite and Affiniti ultrasound systems, approving a suite of AI-powered imaging and automation capabilities designed to standardize routine exams and reduce repeat scanning across users.
2. AI-Driven Measurement and Workflow Automation
The Auto Measure Abdomen feature utilizes AI to automate abdominal measurements with over 93% accuracy and can reduce scanning time by up to 30%, addressing operator variability and improving efficiency in high-volume clinical settings.
3. Integrated Koios AI Decision Support
Elevate Plus now includes on-cart Koios AI software for rapid breast lesion and thyroid nodule classification, offering risk assessments in under two seconds and leveraging a database of more than 350,000 pathology-proven cases.
4. Modular, Upgradable Platform and Imaging Enhancements
The upgrade delivers advanced imaging tools such as XRes Pro+ and Super Res MVI Pro, while its modular design and remote update capabilities aim to extend system lifespan, support tele-health integration and reduce long-term total cost of ownership.
